Risk Reduction for Alzheimer's Disease
Public ClinicalTrials.gov record NCT02913664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Exercise and Intensive Vascular Risk Reduction in Preventing Dementia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Physical inactivity, high blood pressure and dyslipidemia are risk factors for Alzheimer's disease (AD) and vascular dementia. Importantly, these risk factors are modifiable with lifestyle changes, pharmacological treatment, or both. The rrAD study will determine effects of aerobic exercise training and intensive vascular risk reduction on cognitive performance in older adults who have high risk for AD.
Study identification
- NCT ID
- NCT02913664
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 513 participants
Conditions and interventions
Conditions
Interventions
- Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine) Drug
- Aerobic Exercise Training Behavioral
- Usual Care Other
- Stretching Exercise Behavioral
Drug · Behavioral · Other
Eligibility (public fields only)
- Age range
- 60 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2, 2017 (Actual)
- Primary completion
- Nov 30, 2021 (Actual)
- Completion
- Jan 31, 2022 (Actual)
- Last update posted
- Feb 15, 2022
2017 – 2022
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Kansas Medical Center Research Institute | Kansas City | Kansas | 66160 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| Washington University in St. Louis | St Louis | Missouri | 63110 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02913664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 15, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02913664 live on ClinicalTrials.gov.